¼¼°èÀÇ È£Èí¿ë »ê¼Ò °ø±Þ ±â±â ½ÃÀå
Respiratory Oxygen Delivery Devices
»óǰÄÚµå : 1784087
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 283 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,209,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,629,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

È£Èí¿ë »ê¼Ò °ø±Þ ±â±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 198¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 140¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â È£Èí¿ë »ê¼Ò °ø±Þ ±â±â ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 5.9%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 198¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ »ê¼Ò ¸¶½ºÅ©´Â CAGR 5.0%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 55¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ºñ°­ ij´¼¶ó ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 38¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 9.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ È£Èí¿ë »ê¼Ò °ø±Þ ±â±â ½ÃÀåÀº 2024³â¿¡ 38¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 9.1%¸¦ ±â·ÏÇϸç 2030³â±îÁö 40¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 3.0%¿Í 5.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è È£Èí¿ë »ê¼Ò °ø±Þ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

È£Èí¿ë »ê¼Ò °ø±Þ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

È£Èí¿ë »ê¼Ò °ø±Þ ±â±â´Â COPD, õ½Ä, Æó·Å µî ±Þ¼º ¹× ¸¸¼º È£Èí±âÁúȯÀÇ °ü¸®¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. È£Èí±âÁúȯÀÇ À¯º´·ü Áõ°¡´Â Àα¸ °í·ÉÈ­ ¹× ÀÇ·á Á¢±Ù¼º Çâ»ó°ú ÇÔ²² °íÈ¿À² »ê¼Ò Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. º´¿ø, ÀÀ±Þ½Ç, ÀçÅÃÀÇ·á ¾÷ü´Â È£Èí °ï¶õ ȯÀÚ¸¦ Áö¿øÇϱâ À§ÇØ ºñ°­ ij´¼¶ó, »ê¼Ò ¸¶½ºÅ©, ºñħ½ÀÀû ÀΰøÈ£Èí±â µî »ê¼Ò °ø±Þ ±â±â¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. COVID-19 ÆÒµ¥¹Í ±â°£ µ¿¾È ¼ö¿ä°¡ ±ÞÁõÇϸ鼭 ÀÇ·á ½Ã½ºÅÛ¿¡¼­ »ê¼Ò ¿ä¹ýÀÇ Áß¿äÇÑ ¿ªÇÒÀÌ ´õ¿í ºÎ°¢µÇ¾ú°í, »ê¼Ò °ø±Þ ÀÎÇÁ¶ó¿Í ÈÞ´ë¿ë »ê¼Ò¹ß»ý±â¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çß½À´Ï´Ù.

±â¼ú Çõ½ÅÀº »ê¼Ò °ø±Þ ±â±â¸¦ ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

ÈÞ´ë¿ë »ê¼Ò¹ß»ý±â, °í À¯·® ºñ°­ ij´¼¶ó, ºñħ½ÀÀû ȯ±â ½Ã½ºÅÛÀÇ ¹ßÀüÀº È£Èí±â »ê¼Ò ¿ä¹ýÀÇ È¿À²¼º°ú ÆíÀǼºÀ» Çâ»ó½ÃÄ×½À´Ï´Ù. ½Ç½Ã°£ »ê¼ÒÆ÷È­µµ ¸ð´ÏÅ͸µ°ú AI¸¦ ÅëÇÑ À¯·® Á¶ÀýÀÌ °¡´ÉÇÑ ½º¸¶Æ® »ê¼Ò °ø±Þ ½Ã½ºÅÛÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ÒÇüÈ­µÈ ¹èÅ͸® ±¸µ¿½Ä »ê¼Ò¹ß»ý±â´Â Àå±âÀûÀÎ »ê¼Ò ¿ä¹ýÀ» ÇÊ¿ä·Î Çϴ ȯÀÚ¿¡°Ô À̵¿¼ºÀ» Á¦°øÇÕ´Ï´Ù. °¡½À »ê¼Ò ¿ä¹ýÀÇ ±â¼ú Çõ½ÅÀº ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½Ã۰í ÄÚÀÇ °ÇÁ¶ÇÔ°ú ÀÚ±ØÀ» ÁÙ¿©ÁÝ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû °³¼±À¸·Î È£Èí±â¿¡ »ê¼Ò °ø±ÞÀÌ º¸´Ù Ä£¼÷Çϰí È¿À²ÀûÀ̸ç ȯÀÚ Ä£È­ÀûÀÎ ¹æ½ÄÀ¸·Î ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù.

»ê¼Ò °ø±Þ ±â±âÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ½ÃÀå µ¿ÇâÀº ¹«¾ùÀΰ¡?

ÀçÅà ȣÈí Ä¡·á¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ÈÞ´ë¿ë »ê¼Ò ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© º´¿ø ±â¹Ý »ê¼Ò ¿ä¹ý¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãß°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ø°ÝÀÇ·á¿Í ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ ºÎ»óÀ¸·Î ¸¸¼º È£Èí±âÁúȯÀÇ °ü¸®°¡ °­È­µÇ°í, ½Ç½Ã°£ »ê¼Ò ¿ä¹ý Á¶Á¤ÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. µðÁöÅÐ Çコ ¼Ö·ç¼Ç°ú »ê¼Ò°ø±Þ±â±âÀÇ ÅëÇÕÀº ȯÀÚÀÇ ¼øÀÀµµ¿Í Ä¡·á È¿°ú¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °³¹ßµµ»ó±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó°¡ È®´ëµÊ¿¡ µû¶ó ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ »ê¼Ò ¿ä¹ýÀÇ È°¿ë °¡´É¼ºÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

È£Èí¿ë »ê¼Ò °ø±Þ ±â±â ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

È£Èí¿ë »ê¼Ò °ø±Þ ±â±â ¼¼°è ½ÃÀåÀÇ ¼ºÀåÀº È£Èí±âÁúȯ À¯º´·ü Áõ°¡, »ê¼Ò Ä¡·á ±â¼úÀÇ ¹ßÀü, ÈÞ´ë¿ë ¹× °¡Á¤¿ë »ê¼Ò ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÇ·á Á¢±Ù¼º ¹× »ê¼Ò °ø±Þ¸Á °³¼±À» À§ÇÑ Á¤ºÎÀÇ ³ë·ÂÀº ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, AI ±â¹Ý ¸ð´ÏÅ͸µ ±â´ÉÀ» °®Ãá ½º¸¶Æ® È£Èí±â ±â±âÀÇ °³¹ßÀº Ä¡·áÀÇ °³ÀÎÈ­¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ È£Èí±â °Ç°­À» ÃÖ¿ì¼±½ÃÇÏ´Â °¡¿îµ¥, »ê¼Ò °ø±Þ ±â±â ½ÃÀåÀº Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å°ú ÀÇ·á Á¢±Ù¼º È®´ë¿¡ µû¶ó Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

ºÎ¹®

Á¦Ç°(»ê¼Ò ¸¶½ºÅ©, ºñ°­ ij´¼¶ó, º¥Ãò¸® ¸¶½ºÅ©, ºñÈ£Èí ¸¶½ºÅ©, ¹é ¹ëºê ¸¶½ºÅ©, CPAP ¸¶½ºÅ©, ±âŸ), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø, ¿Ü·¡ ȯÀÚ ½Ã¼³, ÀçÅà Äɾî)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°è °íÀ¯ÀÇ SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Respiratory Oxygen Delivery Devices Market to Reach US$19.8 Billion by 2030

The global market for Respiratory Oxygen Delivery Devices estimated at US$14.0 Billion in the year 2024, is expected to reach US$19.8 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Oxygen Masks, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$5.5 Billion by the end of the analysis period. Growth in the Nasal Cannula segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.8 Billion While China is Forecast to Grow at 9.1% CAGR

The Respiratory Oxygen Delivery Devices market in the U.S. is estimated at US$3.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.0 Billion by the year 2030 trailing a CAGR of 9.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Respiratory Oxygen Delivery Devices Market - Key Trends & Drivers Summarized

Why Is the Demand for Respiratory Oxygen Delivery Devices Increasing?

Respiratory oxygen delivery devices have become essential for managing acute and chronic respiratory conditions, including COPD, asthma, and pneumonia. The rising prevalence of respiratory diseases, coupled with aging populations and increasing healthcare accessibility, has fueled demand for high-efficiency oxygen therapy solutions. Hospitals, emergency care units, and home healthcare providers rely on oxygen delivery devices such as nasal cannulas, oxygen masks, and non-invasive ventilators to support patients with breathing difficulties. The surge in demand during the COVID-19 pandemic further highlighted the critical role of oxygen therapy in healthcare systems, leading to increased investment in oxygen supply infrastructure and portable oxygen concentrators.

How Are Technological Innovations Transforming Oxygen Delivery Devices?

Advancements in portable oxygen concentrators, high-flow nasal cannulas, and non-invasive ventilation systems have improved the efficiency and convenience of respiratory oxygen therapy. Smart oxygen delivery systems with real-time oxygen saturation monitoring and AI-driven flow adjustments are enhancing patient outcomes. Additionally, miniaturized and battery-powered oxygen concentrators are providing greater mobility for patients requiring long-term oxygen therapy. Innovations in humidified oxygen therapy have also improved patient comfort, reducing nasal dryness and irritation. These technological improvements are making respiratory oxygen delivery more accessible, efficient, and patient-friendly.

What Market Trends Are Influencing the Growth of Oxygen Delivery Devices?

The increasing preference for home-based respiratory care has driven demand for portable oxygen devices, reducing dependence on hospital-based oxygen therapy. Additionally, the rise of telemedicine and remote patient monitoring has enhanced the management of chronic respiratory conditions, enabling real-time oxygen therapy adjustments. The integration of digital health solutions with oxygen delivery devices is also improving patient compliance and treatment efficacy. Furthermore, the expansion of healthcare infrastructure in developing regions has increased the availability of oxygen therapy in underserved areas.

What Are the Key Growth Drivers of the Respiratory Oxygen Delivery Devices Market?

The growth in the global respiratory oxygen delivery devices market is driven by rising respiratory disease prevalence, advancements in oxygen therapy technology, and increasing demand for portable and home-based oxygen solutions. Government initiatives aimed at improving healthcare access and oxygen supply chains have further supported market expansion. Additionally, the development of smart respiratory devices with AI-based monitoring capabilities is enhancing treatment personalization. As global healthcare systems continue to prioritize respiratory health, the market for oxygen delivery devices is expected to experience sustained growth, driven by ongoing innovation and expanding healthcare accessibility.

SCOPE OF STUDY:

The report analyzes the Respiratory Oxygen Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Oxygen Masks, Nasal Cannula, Venturi Masks, Non-rebreather Masks, Bag Valve Masks, CPAP Masks, Others); End-Use (Hospitals, Outpatient Facilities, Home Care)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â